المؤلفون: Tengfei Xiao, Mitchell Dowsett, Nanlin Li, Teng Fei, Ying Huang, X. Shirley Liu, Eran R. Andrechek, Wei Li, Joseph Geradts, Han Xu, Qiu Wu, Rinath Jeselsohn, David Chi, Myles Brown, Chongzhi Zang, Simone Detre, Jonathan P. Rennhack, Qi Liao, Peng Jiang, Xiaoqing Wang, Jixin Yang

المصدر: Proceedings of the National Academy of Sciences of the United States of America

مصطلحات موضوعية: 0301 basic medicine, Medical Sciences, Antineoplastic Agents, Hormonal, medicine.drug_class, Estrogen receptor, Breast Neoplasms, Gene Expression Regulation, Enzymologic, CRISPR screen, endocrine resistance, CSK Tyrosine-Protein Kinase, 03 medical and health sciences, Breast cancer, breast cancer, Commentaries, CSK, medicine, Endocrine system, Humans, Breast, p21-activated kinases, Multidisciplinary, business.industry, Kinase, Antagonist, Estrogens, Biological Sciences, medicine.disease, 3. Good health, Neoplasm Proteins, Gene Expression Regulation, Neoplastic, 030104 developmental biology, src-Family Kinases, Receptors, Estrogen, p21-Activated Kinases, Estrogen, Drug Resistance, Neoplasm, Cancer research, MCF-7 Cells, Female, business, Proto-oncogene tyrosine-protein kinase Src, estrogen receptor

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da54cd53dc52e74ebfeecf663937af11Test
https://pubmed.ncbi.nlm.nih.gov/30082387Test

المؤلفون: Xiaoyong Fu, Myles Brown, Rachel Schiff, Carolina Gutierrez, Laura M. Heiser, Martin Shea, C. Kent Osborne, Obi L. Griffith, Anna Tsimelzon, Fugen Li, Catherine S. Grasso, Mothaffar F. Rimawi, Pavana Anur, Rinath Jeselsohn, Dolores Lopez-Terrada, Dean P. Edwards, Joe W. Gray, Carmine De Angelis, Emporia F Hollingsworth, Resel Pereira, Susan G. Hilsenbeck, Meghana V. Trivedi, Chad J. Creighton, Agostina Nardone, Paul T. Spellman, Nicholas J. Wang, Shixia Huang

المساهمون: Fu, X., Jeselsohn, R., Pereira, R., Hollingsworth, E. F., Creighton, C. J., Li, F., Shea, M., Nardone, A., De Angelis, C., Heiser, L. M., Anur, P., Wang, N., Grasso, C. S., Spellman, P. T., Griffith, O. L., Tsimelzon, A., Gutierrez, C., Huang, S., Edwards, D. P., Trivedi, M. V., Rimawi, M. F., Lopez-Terrada, D., Hilsenbeck, S. G., Gray, J. W., Brown, M., Osborne, C. K., Schiff, R.

المصدر: Proceedings of the National Academy of Sciences of the United States of America. 113(43)

مصطلحات موضوعية: 0301 basic medicine, Hepatocyte Nuclear Factor 3-alpha, Antineoplastic Agents, Hormonal, Prognosi, Estrogen receptor, Breast Neoplasms, Biology, Transcriptome, 03 medical and health sciences, Breast cancer, Cell Line, Tumor, medicine, Humans, RNA, Small Interfering, Gene knockdown, Multidisciplinary, Pioneer factor, Interleukin-8, Estrogen Receptor alpha, medicine.disease, Prognosis, Survival Analysis, Gene Expression Regulation, Neoplastic, Tamoxifen, 030104 developmental biology, PNAS Plus, Drug Resistance, Neoplasm, Transcriptional reprogramming, Cancer research, Female, Survival Analysi, FOXA1, Estrogen receptor alpha, Breast Neoplasm, Endocrine resistance, Human, medicine.drug, Signal Transduction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed2387c3c513051ae7743e2ef46a0318Test
https://pubmed.ncbi.nlm.nih.gov/27791031Test